StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Medpace's profit margin for the twelve months ending Sep 30, 2026 was 18.2%. For fiscal 2025 it was 17.8%, against 19.2% the year before. The highest annual figure on record is 19.2% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202517.8%−1.3
FY2024Dec 31, 202419.2%+4.2
FY2023Dec 31, 202315.0%−1.8
FY2022Dec 31, 202216.8%+0.9
FY2021Dec 31, 202115.9%+0.2
FY2020Dec 31, 202015.7%+4.0
FY2019Dec 31, 201911.7%+1.3
FY2018Dec 31, 201810.4%+1.4
FY2017Dec 31, 20179.0%+5.8
FY2016Dec 31, 20163.2%+5.6
FY2015Dec 31, 2015-2.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202619.2%+2.4
Q2 FY2026Jun 30, 202617.2%+2.2
Q1 FY2026Mar 31, 202617.5%−3.0
Q4 FY2025Dec 31, 202519.1%−2.7
Q3 FY2025Sep 30, 202516.8%−1.2
Q2 FY2025Jun 30, 202515.0%−1.8
Q1 FY2025Mar 31, 202520.5%+0.4
Q4 FY2024Dec 31, 202421.8%+6.1
Q3 FY2024Sep 30, 202418.1%+3.8
Q2 FY2024Jun 30, 202416.7%+3.5
Q1 FY2024Mar 31, 202420.1%+3.3
Q4 FY2023Dec 31, 202315.7%−1.7
Q3 FY2023Sep 30, 202314.3%−2.9
Q2 FY2023Jun 30, 202313.3%−0.8
Q1 FY2023Mar 31, 202316.8%−1.7
Q4 FY2022Dec 31, 202217.4%+1.2
Q3 FY2022Sep 30, 202217.2%+0.8
Q2 FY2022Jun 30, 202214.1%−0.3
Q1 FY2022Mar 31, 202218.5%+1.9
Q4 FY2021Dec 31, 202116.2%−3.4
Q3 FY2021Sep 30, 202116.4%−1.6
Q2 FY2021Jun 30, 202114.3%+2.6
Q1 FY2021Mar 31, 202116.7%+4.1
Q4 FY2020Dec 31, 202019.6%+6.6
Q3 FY2020Sep 30, 202018.0%+6.9
Q2 FY2020Jun 30, 202011.8%−1.1
Q1 FY2020Mar 31, 202012.5%+3.0
Q4 FY2019Dec 31, 201913.0%+1.1
Q3 FY2019Sep 30, 201911.1%+0.3
Q2 FY2019Jun 30, 201912.8%+3.1
Q1 FY2019Mar 31, 20199.6%+0.6
Q4 FY2018Dec 31, 201811.8%+1.8
Q3 FY2018Sep 30, 201810.8%+1.9
Q2 FY2018Jun 30, 20189.7%+0.7
Q1 FY2018Mar 31, 20188.9%+1.0
Q4 FY2017Dec 31, 201710.0%+10.0
Q3 FY2017Sep 30, 20178.9%–
Q2 FY2017Jun 30, 20179.0%–
Q1 FY2017Mar 31, 20177.9%–
Q4 FY2016Dec 31, 2016-0.0%–

More Medpace figures

See a number that looks wrong?